3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
6
Suspended
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
22
fludarabine
17
Specimen Handling
13
Nivolumab
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Radiotherapy
6
Cisplatin
6
fludarabine phosphate
5
Interleukin-2
5
Injections
5
Doxorubicin
5
tislelizumab
4
daratumumab
4
Paclitaxel
4
Ipilimumab
4
Immune Checkpoint Inhibitors
4
Drug Therapy
4
Dexamethasone
4
Carboplatin
4
Biopsy
4
venetoclax
3
trastuzumab deruxtecan
3
toripalimab
3
ruxolitinib
3
X-Rays
3
Vincristine
3
Rituximab
3
Radiosurgery
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Protein Subunit Vaccines
×
Clear all
NCT06252584
2024-02-09
AML-VAC-XS15
University Hospital Tuebingen
Phase 1
Not yet recruiting
20 enrolled